Our knowledge of pluripotent stem cell (PSC) biology has advanced to the point where we now can generate most cells of the human body in the laboratory. PSC-derived cardiomyocytes can be generated routinely with high yield and purity for disease research and drug development, and these cells are now gradually entering the clinical research phase for the testing of heart regeneration therapies. However, a major hurdle for their applications is the immature state of these cardiomyocytes. In this Review, we describe the structural and functional properties of cardiomyocytes and present the current approaches to mature PSC-derived cardiomyocytes. To date, the greatest success in maturation of PSC-derived cardiomyocytes has been with transplantation into the heart in animal models and the engineering of 3D heart tissues with electromechanical conditioning. In conventional 2D cell culture, biophysical stimuli such as mechanical loading, electrical stimulation and nanotopology cues all induce substantial maturation, particularly of the contractile cytoskeleton. Metabolism has emerged as a potent means to control maturation with unexpected effects on electrical and mechanical function. Different interventions induce distinct facets of maturation, suggesting that activating multiple signalling networks might lead to increased maturation. Despite considerable progress, we are still far from being able to generate PSC-derived cardiomyocytes with adult-like phenotypes in vitro. Future progress will come from identifying the developmental drivers of maturation and leveraging them to create more mature cardiomyocytes for research and regenerative medicine.
Cardiomyocytes can be generated in vitro from stem cells with high throughput and purity at a clinically relevant scale, although their differentiation status resembles an embryonic state.
Cardiomyocyte maturation entails adoption of multiple complex phenotypes, and a number of methods to mature stem cell-derived cardiomyocytes have been successful in driving the cells towards a postnatal state.
Stem cell-derived cardiomyocyte phenotypes have been characterized with the use of global systems approaches, which has uncovered novel regulators and insights for maturation.
Moving forward, strategies for cardiomyocyte maturation will require indication-specific optimization for intended applications of stem cell-derived cardiomyocytes, leveraging an optimal maturation state while utilizing combinatorial approaches.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Dynamic chromatin landscape encodes programs for perinatal transition of cardiomyocytes
Cell Death Discovery Open Access 18 January 2023
Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes
Stem Cell Research & Therapy Open Access 27 December 2022
Time-regulated transcripts with the potential to modulate human pluripotent stem cell-derived cardiomyocyte differentiation
Stem Cell Research & Therapy Open Access 02 September 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Liu, Y. W. et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat. Biotechnol. 36, 597–605 (2018).
Sizarov, A. et al. Formation of the building plan of the human heart: morphogenesis, growth, and differentiation. Circulation 123, 1125–1135 (2011).
Marchiano, S., Bertero, A. & Murry, C. E. Learn from your elders: developmental biology lessons to guide maturation of stem cell-derived cardiomyocytes. Pediatr. Cardiol. 40, 1367–1387 (2019).
Hudlicka, O. & Brown, M. D. Postnatal growth of the heart and its blood vessels. J. Vasc. Res. 33, 266–287 (1996).
Hew, K. W. & Keller, K. A. Postnatal anatomical and functional development of the heart: a species comparison. Birth Defects Res. B Dev. Reprod. Toxicol. 68, 309–320 (2003).
Mollova, M. et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl Acad. Sci. USA 110, 1446–1451 (2013).
Gilsbach, R. et al. Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. Nat. Commun. 9, 391 (2018).
Porter, G. A. Jr. et al. Bioenergetics, mitochondria, and cardiac myocyte differentiation. Prog. Pediatr. Cardiol. 31, 75–81 (2011).
Siedner, S. et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J. Physiol. 548, 493–505 (2003).
Christoffels, V. M., Smits, G. J., Kispert, A. & Moorman, A. F. Development of the pacemaker tissues of the heart. Circ. Res. 106, 240–254 (2010).
Spater, D., Hansson, E. M., Zangi, L. & Chien, K. R. How to make a cardiomyocyte. Development 141, 4418–4431 (2014).
Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198–205 (2002).
Vreeker, A. et al. Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart. PLoS One 9, e94722 (2014).
Li, F., Wang, X., Capasso, J. M. & Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell Cardiol. 28, 1737–1746 (1996).
Laflamme, M. A. & Murry, C. E. Heart regeneration. Nature 473, 326–335 (2011).
Lundy, S. D., Zhu, W. Z., Regnier, M. & Laflamme, M. A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Dev. 22, 1991–2002 (2013).
McCain, M. L., Agarwal, A., Nesmith, H. W., Nesmith, A. P. & Parker, K. K. Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials 35, 5462–5471 (2014).
Dai, D. F., Danoviz, M. E., Wiczer, B., Laflamme, M. A. & Tian, R. Mitochondrial maturation in human pluripotent stem cell derived cardiomyocytes. Stem Cell Int. 2017, 5153625 (2017).
Yang, X., Pabon, L. & Murry, C. E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511–523 (2014).
Gerdes, A. M. et al. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86, 426–430 (1992).
Snir, M. et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285, H2355–H2363 (2003).
Spach, M. S., Heidlage, J. F., Dolber, P. C. & Barr, R. C. Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. Circ. Res. 86, 302–311 (2000).
Spach, M. S., Heidlage, J. F., Barr, R. C. & Dolber, P. C. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm. 1, 500–515 (2004).
McCain, M. L. & Parker, K. K. Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function. Pflugers Arch. 462, 89–104 (2011).
Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733–2740 (2003).
Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30–e41 (2009).
Liu, J., Laksman, Z. & Backx, P. H. The electrophysiological development of cardiomyocytes. Adv. Drug. Deliv. Rev. 96, 253–273 (2016).
Carmeliet, E. Pacemaking in cardiac tissue. From IK2 to a coupled-clock system. Physiol. Rep. 7, e13862 (2019).
Peinkofer, G. et al. From early embryonic to adult stage: comparative study of action potentials of native and pluripotent stem cell-derived cardiomyocytes. Stem Cell Dev. 25, 1397–1406 (2016).
Koivumaki, J. T. et al. Structural immaturity of human iPSC-derived cardiomyocytes: in silico investigation of effects on function and disease modeling. Front. Physiol. 9, 80 (2018).
Veerman, C. C. et al. Switch from fetal to adult SCN5A isoform in human induced pluripotent stem cell-derived cardiomyocytes unmasks the cellular phenotype of a conduction disease-causing mutation. J. Am. Heart Assoc. 6, e005135 (2017).
Buchanan, J. W. Jr., Saito, T. & Gettes, L. S. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ. Res. 56, 696–703 (1985).
Hoekstra, M., Mummery, C. L., Wilde, A. A., Bezzina, C. R. & Verkerk, A. O. Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front. Physiol. 3, 346 (2012).
Zhao, Z. et al. Ion channel expression and characterization in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Int. 2018, 6067096 (2018).
Doss, M. X. et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS One 7, e40288 (2012).
Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010).
Ma, J. et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 301, H2006–H2017 (2011).
Zhang, M. et al. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc. Natl Acad. Sci. USA 111, E5383–E5392 (2014).
Sogo, T. et al. Electrophysiological properties of iPS cell-derived cardiomyocytes from a patient with long QT syndrome type 1 harboring the novel mutation M437V of KCNQ1. Regen. Ther. 4, 9–17 (2016).
Zeng, H., Wang, J., Clouse, H., Lagrutta, A. & Sannajust, F. Human-induced pluripotent stem cell-derived cardiomyocytes have limited IKs for repolarization reserve as revealed by specific KCNQ1/KCNE1 blocker. JRSM Cardiovasc. Dis. 8, 2048004019854919 (2019).
Cordeiro, J. M. et al. Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. J. Mol. Cell Cardiol. 60, 36–46 (2013).
Scuderi, G. J. & Butcher, J. Naturally engineered maturation of cardiomyocytes. Front. Cell Dev. Biol. 5, 50 (2017).
McDevitt, T. C. et al. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J. Biomed. Mater. Res. 60, 472–479 (2002).
Salameh, A. et al. Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin43. Circ. Res. 106, 1592–1602 (2010).
Zhang, W. et al. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: effects of niche cell supplementation and mechanical stimulation. Acta Biomater. 49, 204–217 (2017).
Satin, J. et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cell 26, 1961–1972 (2008).
Lieu, D. K. et al. Absence of transverse tubules contributes to non-uniform Ca2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cell Dev. 18, 1493–1500 (2009).
Hwang, H. S. et al. Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories. J. Mol. Cell Cardiol. 85, 79–88 (2015).
Louch, W. E., Koivumaki, J. T. & Tavi, P. Calcium signalling in developing cardiomyocytes: implications for model systems and disease. J. Physiol. 593, 1047–1063 (2015).
Liu, J. et al. Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am. J. Physiol. Cell Physiol. 297, C152–C159 (2009).
Liu, J., Fu, J. D., Siu, C. W. & Li, R. A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cell 25, 3038–3044 (2007).
Davis, J. P. & Tikunova, S. B. Ca2+ exchange with troponin C and cardiac muscle dynamics. Cardiovasc. Res. 77, 619–626 (2008).
Kane, C., Couch, L. & Terracciano, C. M. Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes. Front. Cell Dev. Biol. 3, 59 (2015).
Bird, S. D. et al. The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423–434 (2003).
Bedada, F. B. et al. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Rep. 3, 594–605 (2014).
Zuppinger, C. et al. Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes. Eur. J. Histochem. 61, 2763 (2017).
Iorga, B. et al. Differences in contractile function of myofibrils within human embryonic stem cell-derived cardiomyocytes vs. adult ventricular myofibrils are related to distinct sarcomeric protein isoforms. Front. Physiol. 8, 1111 (2017).
Hinson, J. T. et al. Heart disease. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349, 982–986 (2015).
Mahdavi, V., Lompre, A. M., Chambers, A. P. & Nadal-Ginard, B. Cardiac myosin heavy chain isozymic transitions during development and under pathological conditions are regulated at the level of mRNA availability. Eur. Heart J. 5, 181–191 (1984).
Weber, N. et al. Stiff matrix induces switch to pure beta-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes. Basic. Res. Cardiol. 111, 68 (2016).
Sabry, M. A. & Dhoot, G. K. Identification and pattern of expression of a developmental isoform of troponin I in chicken and rat cardiac muscle. J. Muscle Res. Cell Motil. 10, 85–91 (1989).
Gorza, L., Ausoni, S., Merciai, N., Hastings, K. E. & Schiaffino, S. Regional differences in troponin I isoform switching during rat heart development. Dev. Biol. 156, 253–264 (1993).
Hunkeler, N. M., Kullman, J. & Murphy, A. M. Troponin I isoform expression in human heart. Circ. Res. 69, 1409–1414 (1991).
Sasse, S. et al. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ. Res. 72, 932–938 (1993).
Metzger, J. M., Michele, D. E., Rust, E. M., Borton, A. R. & Westfall, M. V. Sarcomere thin filament regulatory isoforms. Evidence of a dominant effect of slow skeletal troponin I on cardiac contraction. J. Biol. Chem. 278, 13118–13123 (2003).
Westfall, M. V., Rust, E. M. & Metzger, J. M. Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc. Natl Acad. Sci. USA 94, 5444–5449 (1997).
Davis, J. P. et al. Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys. J. 92, 3195–3206 (2007).
Chuva de Sousa Lopes, S. M. et al. Patterning the heart, a template for human cardiomyocyte development. Dev. Dyn. 235, 1994–2002 (2006).
Piccini, I., Rao, J., Seebohm, G. & Greber, B. Human pluripotent stem cell-derived cardiomyocytes: genome-wide expression profiling of long-term in vitro maturation in comparison to human heart tissue. Genom. Data 4, 69–72 (2015).
Clement, S. et al. Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J. Cell Sci. 120, 229–238 (2007).
Black, F. M. et al. The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load. J. Clin. Invest. 88, 1581–1588 (1991).
Suurmeijer, A. J. et al. Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J. Pathol. 199, 387–397 (2003).
van Laake, L. W. et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1, 9–24 (2007).
Kim, H. D. Expression of intermediate filament desmin and vimentin in the human fetal heart. Anat. Rec. 246, 271–278 (1996).
Werner, J. C., Sicard, R. E. & Schuler, H. G. Palmitate oxidation by isolated working fetal and newborn pig hearts. Am. J. Physiol. 256, E315–E321 (1989).
Lopaschuk, G. D., Spafford, M. A. & Marsh, D. R. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am. J. Physiol. 261, H1698–H1705 (1991).
Stanley, W. C., Recchia, F. A. & Lopaschuk, G. D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093–1129 (2005).
Galdos, F. X. et al. Cardiac regeneration: lessons from development. Circ. Res. 120, 941–959 (2017).
Palmer, J. W., Tandler, B. & Hoppel, C. L. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem. 252, 8731–8739 (1977).
Saks, V. et al. Intracellular energetic units regulate metabolism in cardiac cells. J. Mol. Cell Cardiol. 52, 419–436 (2012).
Hom, J. R. et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev. Cell 21, 469–478 (2011).
Feric, N. T. & Radisic, M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug. Deliv. Rev. 96, 110–134 (2016).
Adler, C. P. & Friedburg, H. Myocardial DNA content, ploidy level and cell number in geriatric hearts: post-mortem examinations of human myocardium in old age. J. Mol. Cell Cardiol. 18, 39–53 (1986).
Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98–102 (2009).
Brodsky, W. Y., Arefyeva, A. M. & Uryvaeva, I. V. Mitotic polyploidization of mouse heart myocytes during the first postnatal week. Cell Tissue Res. 210, 133–144 (1980).
Soonpaa, M. H., Kim, K. K., Pajak, L., Franklin, M. & Field, L. J. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271, H2183–H2189 (1996).
Puente, B. N. et al. The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157, 565–579 (2014).
Hirose, K. et al. Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science 364, 184–188 (2019).
Herget, G. W., Neuburger, M., Plagwitz, R. & Adler, C. P. DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. Cardiovasc. Res. 36, 45–51 (1997).
Adler, C. P. Relationship between deoxyribonucleic acid content and nucleoli in human heart muscle cells and estimation of cell number during cardiac growth and hyperfunction. Recent. Adv. Stud. Card. Struct. Metab. 8, 373–386 (1975).
Patterson, M. et al. Frequency of mononuclear diploid cardiomyocytes underlies natural variation in heart regeneration. Nat. Genet. 49, 1346–1353 (2017).
Gonzalez-Rosa, J. M. et al. Myocardial polyploidization creates a barrier to heart regeneration in zebrafish. Dev. Cell 44, 433–446.e7 (2018).
Brooks, G., Poolman, R. A., McGill, C. J. & Li, J. M. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J. Mol. Cell. Cardiol. 29, 2261–2271 (1997).
Kang, M. J., Kim, J. S., Chae, S. W., Koh, K. N. & Koh, G. Y. Cyclins and cyclin dependent kinases during cardiac development. Mol. Cells 7, 360–366 (1997).
Yoshizumi, M. et al. Disappearance of cyclin a correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J. Clin. Invest. 95, 2275–2280 (1995).
Koh, K. N. et al. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. J. Mol. Cell Cardiol. 30, 463–474 (1998).
Pasumarthi, K. B. & Field, L. J. Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044–1054 (2002).
Burton, P. B., Yacoub, M. H. & Barton, P. J. Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur. Heart J. 20, 604–611 (1999).
Uosaki, H. et al. Transcriptional landscape of cardiomyocyte maturation. Cell Rep. 13, 1705–1716 (2015).
Shadrin, I. Y. et al. Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat. Commun. 8, 1825 (2017).
Correia, C. et al. Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci. Rep. 7, 8590 (2017).
Mohamed, T. M. A. et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173, 104–116.e12 (2018).
Yang, X. et al. Tri-iodo-L-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J. Mol. Cell Cardiol. 72, 296–304 (2014).
Diez-Cunado, M. et al. miRNAs that induce human cardiomyocyte proliferation converge on the hippo pathway. Cell Rep. 23, 2168–2174 (2018).
Zhou, Q., Li, L., Zhao, B. & Guan, K. L. The hippo pathway in heart development, regeneration, and diseases. Circulation Res. 116, 1431–1447 (2015).
Mahmoud, A. I. et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 497, 249–253 (2013).
Nakano, H. et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. eLife 6, e29330 (2017).
Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372–E8381 (2017).
Hassink, R. J. et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78, 18–25 (2008).
Zhu, W., Zhao, M., Mattapally, S., Chen, S. & Zhang, J. CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle. Circ. Res. 122, 88–96 (2018).
Kamakura, T. et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ. J. 77, 1307–1314 (2013).
Churko, J. M. et al. Defining human cardiac transcription factor hierarchies using integrated single-cell heterogeneity analysis. Nat. Commun. 9, 4906 (2018).
Friedman, C. E. et al. Single-cell transcriptomic analysis of cardiac differentiation from human PSCs reveals HOPX-dependent cardiomyocyte maturation. Cell Stem Cell 23, 586–598.e8 (2018).
Kuppusamy, K. T. et al. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc. Natl Acad. Sci. USA 112, E2785–E2794 (2015).
Kadota, S., Pabon, L., Reinecke, H. & Murry, C. E. In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Rep. 8, 278–289 (2017).
Cho, G. S. et al. Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy. Cell Rep. 18, 571–582 (2017).
Funakoshi, S. et al. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci. Rep. 6, 19111 (2016).
Laflamme, M. A. et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167, 663–671 (2005).
Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273–277 (2014).
Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388–391 (2016).
Gerbin, K. A. & Murry, C. E. The winding road to regenerating the human heart. Cardiovasc. Pathol. 24, 133–140 (2015).
Guo, Y. et al. Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factor. Nat. Commun. 9, 3837 (2018).
Ackers-Johnson, M. et al. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res. 119, 909–920 (2016).
Banyasz, T. et al. Transformation of adult rat cardiac myocytes in primary culture. Exp. Physiol. 93, 370–382 (2008).
Claycomb, W. C. & Palazzo, M. C. Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscope study. Dev. Biol. 80, 466–482 (1980).
Ribeiro, A. J. et al. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Proc. Natl Acad. Sci. USA 112, 12705–12710 (2015).
Kim, D. H. et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc. Natl Acad. Sci. USA 107, 565–570 (2010).
Macadangdang, J. et al. Nanopatterned human iPSC-based model of a dystrophin-null cardiomyopathic phenotype. Cell Mol. Bioeng. 8, 320–332 (2015).
Rao, C. et al. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 34, 2399–2411 (2013).
Werley, C. A. et al. Geometry-dependent functional changes in iPSC-derived cardiomyocytes probed by functional imaging and RNA sequencing. PLoS One 12, e0172671 (2017).
Huethorst, E. et al. Enhanced human-induced pluripotent stem cell derived cardiomyocyte maturation using a dual microgradient substrate. ACS Biomater. Sci. Eng. 2, 2231–2239 (2016).
Jacot, J. G. et al. Cardiac myocyte force development during differentiation and maturation. Ann. NY Acad. Sci. 1188, 121–127 (2010).
Martewicz, S., Serena, E., Zatti, S., Keller, G. & Elvassore, N. Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance. Stem Cell Res. 25, 107–114 (2017).
Feaster, T. K. et al. Matrigel mattress: a method for the generation of single contracting human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 117, 995–1000 (2015).
Herron, T. J. et al. Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circ. Arrhythm. Electrophysiol. 9, e003638 (2016).
Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400–409 (2016).
Ieda, M. et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev. Cell 16, 233–244 (2009).
Bergmann, O. et al. Dynamics of cell generation and turnover in the human heart. Cell 161, 1566–1575 (2015).
Tirziu, D., Giordano, F. J. & Simons, M. Cell communications in the heart. Circulation 122, 928–937 (2010).
Fountoulaki, K., Dagres, N. & Iliodromitis, E. K. Cellular communications in the heart. Card. Fail. Rev. 1, 64–68 (2015).
Brutsaert, D. L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 83, 59–115 (2003).
Yu, J. et al. Topological arrangement of cardiac fibroblasts regulates cellular plasticity. Circ. Res. 123, 73–85 (2018).
Herum, K. M., Choppe, J., Kumar, A., Engler, A. J. & McCulloch, A. D. Mechanical regulation of cardiac fibroblast profibrotic phenotypes. Mol. Biol. Cell 28, 1871–1882 (2017).
Lee, D. S. et al. Defined microRNAs induce aspects of maturation in mouse and human embryonic-stem-cell-derived cardiomyocytes. Cell Rep. 12, 1960–1967 (2015).
Dunn, K. K. et al. Coculture of endothelial cells with human pluripotent stem cell-derived cardiac progenitors reveals a differentiation stage-specific enhancement of cardiomyocyte maturation. Biotechnol. J. 14, e1800725 (2019).
Zuppinger, C. 3D culture for cardiac cells. Biochim. Biophys. Acta 1863, 1873–1881 (2016).
Hirt, M. N., Hansen, A. & Eschenhagen, T. Cardiac tissue engineering: state of the art. Circ. Res. 114, 354–367 (2014).
Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239–243 (2018).
Ulmer, B. M. et al. Contractile work contributes to maturation of energy metabolism in hiPSC-derived cardiomyocytes. Stem Cell Rep. 10, 834–847 (2018).
Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016).
Lemoine, M. D. et al. Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci. Rep. 7, 5464 (2017).
Zhang, D. et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34, 5813–5820 (2013).
Schaaf, S. et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 6, e26397 (2011).
Tiburcy, M. et al. Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair. Circulation 135, 1832–1847 (2017).
Bargehr, J. et al. Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration. Nat. Biotechnol. 37, 895–906 (2019).
Ravenscroft, S. M., Pointon, A., Williams, A. W., Cross, M. J. & Sidaway, J. E. Cardiac non-myocyte cells show enhanced pharmacological function suggestive of contractile maturity in stem cell derived cardiomyocyte microtissues. Toxicol. Sci. 152, 99–112 (2016).
Giacomelli, E. et al. Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells. Development 144, 1008–1017 (2017).
Lindsey, S. E., Butcher, J. T. & Yalcin, H. C. Mechanical regulation of cardiac development. Front. Physiol. 5, 318 (2014).
Ruwhof, C. & van der Laarse, A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 47, 23–37 (2000).
Judd, J., Lovas, J. & Huang, G. N. Isolation, culture and transduction of adult mouse cardiomyocytes. J. Vis. Exp. 87, 54012 (2016).
Zimmermann, W. H. et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–230 (2002).
Tulloch, N. L. et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109, 47–59 (2011).
Ruan, J. L. et al. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134, 1557–1567 (2016).
Wiegerinck, R. F. et al. Force frequency relationship of the human ventricle increases during early postnatal development. Pediatr. Res. 65, 414–419 (2009).
Leonard, A. et al. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. J. Mol. Cell Cardiol. 118, 147–158 (2018).
Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101, 18129–18134 (2004).
Godier-Furnemont, A. F. et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials 60, 82–91 (2015).
Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10, 781–787 (2013).
Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913–927.e18 (2019).
Eng, G. et al. Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat. Commun. 7, 10312 (2016).
Hasenfuss, G. et al. Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ. Res. 68, 836–846 (1991).
Ronaldson-Bouchard, K. et al. Author correction: advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 572, E16–E17 (2019).
Li, M. et al. Thyroid hormone action in postnatal heart development. Stem Cell Res. 13, 582–591 (2014).
Rog-Zielinska, E. A. et al. Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1α. Cell Death Differ. 22, 1106–1116 (2015).
Rog-Zielinska, E. A. et al. Glucocorticoid receptor is required for foetal heart maturation. Hum. Mol. Genet. 22, 3269–3282 (2013).
Birket, M. J. et al. PGC-1alpha and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep. 1, 560–574 (2013).
Parikh, S. S. et al. Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 121, 1323–1330 (2017).
Foldes, G. et al. Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J. Mol. Cell Cardiol. 50, 367–376 (2011).
Wu, L. et al. Angiotensin II promotes cardiac differentiation of embryonic stem cells via angiotensin type 1 receptor. Differentiation 86, 23–29 (2013).
Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387–407 (2018).
Troncoso, R., Ibarra, C., Vicencio, J. M., Jaimovich, E. & Lavandero, S. New insights into IGF-1 signaling in the heart. Trends Endocrinol. Metab. 25, 128–137 (2014).
McDevitt, T. C., Laflamme, M. A. & Murry, C. E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J. Mol. Cell Cardiol. 39, 865–873 (2005).
Meyer, D. & Birchmeier, C. Multiple essential functions of neuregulin in development. Nature 378, 386–390 (1995).
Lee, K. F. et al. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378, 394–398 (1995).
Gassmann, M. et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390–394 (1995).
Rupert, C. E. & Coulombe, K. L. K. IGF1 and NRG1 enhance proliferation, metabolic maturity, and the force-frequency response in hESC-derived engineered cardiac tissues. Stem Cell Int. 2017, 7648409 (2017).
Yang, X. et al. Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep. 13, 657–668 (2019).
Courtnay, R. et al. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol. Biol. Rep. 42, 841–851 (2015).
Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177–185 (2006).
Semenza, G. L. et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529–32537 (1996).
Hu, D. et al. Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1alpha and LDHA. Circ. Res. 123, 1066–1079 (2018).
Menendez-Montes, I. et al. Myocardial VHL-HIF signaling controls an embryonic metabolic switch essential for cardiac maturation. Dev. Cell 39, 724–739 (2016).
van den Berg, C. W. et al. Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells. Development 142, 3231–3238 (2015).
Fu, J. D. et al. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One 6, e27417 (2011).
Miklas, J. W. et al. TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes. Nat. Commun. 10, 4671 (2019).
Poon, E. N. et al. Integrated transcriptomic and regulatory network analyses identify microRNA-200c as a novel repressor of human pluripotent stem cell-derived cardiomyocyte differentiation and maturation. Cardiovasc. Res. 114, 894–906 (2018).
Yang, B. et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13, 486–491 (2007).
Chow, M. Z. et al. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Stem Cell Dev. 22, 2678–2690 (2013).
Poon, E. et al. Proteomic analysis of human pluripotent stem cell-derived, fetal, and adult ventricular cardiomyocytes reveals pathways crucial for cardiac metabolism and maturation. Circ. Cardiovasc. Genet. 8, 427–436 (2015).
Hellen, N. et al. Proteomic analysis reveals temporal changes in protein expression in human induced pluripotent stem cell-derived cardiomyocytes in vitro. Stem Cell Dev. 28, 565–578 (2019).
Bhute, V. J. et al. Metabolomics identifies metabolic markers of maturation in human pluripotent stem cell-derived cardiomyocytes. Theranostics 7, 2078–2091 (2017).
Correia, C. et al. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes. Biotechnol. Bioeng. 115, 630–644 (2018).
Palpant, N. J. et al. Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells. Nat. Protoc. 12, 15–31 (2017).
Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162–175 (2013).
Chen, V. C. et al. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res. 15, 365–375 (2015).
Jackman, C., Li, H. & Bursac, N. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function. Acta Biomater. 78, 98–110 (2018).
Reinecke, H., Zhang, M., Bartosek, T. & Murry, C. E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193–202 (1999).
Nakamura, K. & Murry, C. E. Function follows form — a review of cardiac cell therapy. Circ. J. 83, 2399–2412 (2019).
Sylva, M., van den Hoff, M. J. & Moorman, A. F. Development of the human heart. Am. J. Med. Genet. A 164A, 1347–1371 (2014).
Rochais, F., Mesbah, K. & Kelly, R. G. Signaling pathways controlling second heart field development. Circ. Res. 104, 933–942 (2009).
Manner, J. The anatomy of cardiac looping: a step towards the understanding of the morphogenesis of several forms of congenital cardiac malformations. Clin. Anat. 22, 21–35 (2009).
Kelly, R. G., Buckingham, M. E. & Moorman, A. F. Heart fields and cardiac morphogenesis. Cold Spring Harb. Perspect. Med. 4, a015750 (2014).
Del Monte-Nieto, G. et al. Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. Nature 557, 439–445 (2018).
Zhang, W., Chen, H., Qu, X., Chang, C. P. & Shou, W. Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC). Am. J. Med. Genet. C. Semin. Med. Genet. 163C, 144–156 (2013).
Lunkenheimer, P. P. et al. Three-dimensional architecture of the left ventricular myocardium. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 288, 565–578 (2006).
Sosnovik, D. E. & Geva, T. Imaging the microstructure of the human fetal heart. Circ. Cardiovasc. Imaging 11, e008298 (2018).
MacGrogan, D., Munch, J. & de la Pompa, J. L. Notch and interacting signalling pathways in cardiac development, disease, and regeneration. Nat. Rev. Cardiol. 15, 685–704 (2018).
Paige, S. L., Plonowska, K., Xu, A. & Wu, S. M. Molecular regulation of cardiomyocyte differentiation. Circ. Res. 116, 341–353 (2015).
Stankunas, K. et al. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev. Cell 14, 298–311 (2008).
Sedmera, D. & Thompson, R. P. Myocyte proliferation in the developing heart. Dev. Dyn. 240, 1322–1334 (2011).
Olivetti, G. et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J. Mol. Cell Cardiol. 28, 1463–1477 (1996).
Poindexter, B. J., Smith, J. R., Buja, L. M. & Bick, R. J. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium 30, 373–382 (2001).
Horackova, M. & Byczko, Z. Differences in the structural characteristics of adult guinea pig and rat cardiomyocytes during their adaptation and maintenance in long-term cultures: confocal microscopy study. Exp. Cell Res. 237, 158–175 (1997).
Mitcheson, J. S., Hancox, J. C. & Levi, A. J. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc. Res. 39, 280–300 (1998).
Janssen, P. M., Lehnart, S. E., Prestle, J. & Hasenfuss, G. Preservation of contractile characteristics of human myocardium in multi-day cell culture. J. Mol. Cell. Cardiol. 31, 1419–1427 (1999).
Qiao, Y. et al. Multiparametric slice culture platform for the investigation of human cardiac tissue physiology. Prog. Biophy. Mol. Biol. 144, 139–150 (2018).
Brandenburger, M. et al. Organotypic slice culture from human adult ventricular myocardium. Cardiovasc. Res. 93, 50–59 (2012).
Watson, S. A. et al. Preparation of viable adult ventricular myocardial slices from large and small mammals. Nat. Protoc. 12, 2623–2639 (2017).
Ou, Q. et al. Physiological biomimetic culture system for pig and human heart slices. Circ. Res. 125, 628–642 (2019).
Leone, M., Musa, G. & Engel, F. B. Cardiomyocyte binucleation is associated with aberrant mitotic microtubule distribution, mislocalization of RhoA and IQGAP3, as well as defective actomyosin ring anchorage and cleavage furrow ingression. Cardiovasc. Res. 114, 1115–1131 (2018).
Engel, F. B. Cardiomyocyte proliferation: a platform for mammalian cardiac repair. Cell Cycle 4, 1360–1363 (2005).
Hesse, M. et al. Midbody positioning and distance between daughter nuclei enable unequivocal identification of cardiomyocyte cell division in mice. Circ. Res. 123, 1039–1052 (2018).
Chopra, A. et al. Force generation via β-cardiac myosin, titin, and α-actinin drives cardiac sarcomere assembly from cell-matrix adhesions. Developmental Cell 44, 87–96.e5 (2018).
Fenix, A. M. et al. Muscle-specific stress fibers give rise to sarcomeres in cardiomyocytes. eLife 7, e42144 (2018).
Ueno, S. et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl Acad. Sci. USA 104, 9685–9690 (2007).
Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661–680 (2008).
Horvath, A. et al. Low resting membrane potential and low inward rectifier potassium currents are not inherent features of hiPSC-derived cardiomyocytes. Stem Cell Rep. 10, 822–833 (2018).
We thank the members of the Murry Laboratory for productive discussions on the biology of cardiac maturation. We also thank our peer-reviewers, who made this manuscript better. The authors’ work is supported in part by NIH grants R01HL128362, U54DK107979, R01HL141570, R01HL146868 and R01HL128368, an award from the Fondation Leducq Transatlantic Network of Excellence and a grant from the Robert B. McMillen Foundation. N.M. is supported by a fellowship from the Japan Society for the Promotion of Science.
C.E.M. is a scientific founder and equity holder in Sana Biotechnology. The other authors declare no competing interests.
Peer review information
Nature Reviews Cardiology thanks M. Radisic, W. Zimmermann and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Pluripotent stem cells
Stem cells with the capacity to differentiate into any cell type of the embryo. This term encompasses embryonic stem cells and induced pluripotent stem cells.
- Embryonic stages
In humans, the first trimester of in utero development.
- Fetal stages
In humans, the second and third trimesters of in utero development.
- Immature cardiomyocytes
Underdeveloped cardiomyocytes that lack the characteristics of adult cardiomyocytes.
The state in which cells or organisms have more than two complete sets of chromosomes.
- Membrane capacitance
Ratio of electric charge to membrane potential that is directly proportional to the cell surface area.
- Mature cardiomyocytes
Cardiomyocytes that are fully developed and resemble in vivo adult cells in structure and function.
The capacity to stretch or otherwise deform in response to a change in tension, mathematically defined as the change in length (strain) divided by the change in force (stress).
Force transmitted axially during contraction or relaxation.
(miRNAs). Small non-coding RNAs (~20 nucleotides) that downregulate protein levels through post-transcriptional regulation of mRNA.
- Human induced pluripotent stem cell
(hiPSC). Stem cell generated by reprogramming a terminally differentiated, somatic cell to a pluripotent state.
Genetically distinct but from the same species.
- Elastic modulus
The stiffness of a material, mathematically defined as the change in stress divided by the change in strain (that is, the reciprocal of compliant).
A commercially available extracellular matrix secreted by mouse sarcoma cells.
The principal fibrillar extracellular matrix protein in the heart.
A blood protein that self-assembles into a nanofiber meshwork; its natural function is in blood coagulation, but it has been repurposed for tissue engineering scaffolds.
- Isometric contractile force
A contraction in which tension increases without changes in muscle length.
- Frank–Starling relationship
The property of heart muscle whereby an increase in resting tension (preload) linearly increases the strength of contraction.
- Force–frequency relationship
The property of mature heart muscle in which increasing frequency of stimulation results in greater force generation.
Tension on cardiomyocytes experienced during systole, typically provided by blood pressure.
- Auxotonic contraction
A form of contraction in which the muscle shortens against a changing tension.
Structure in the cardiomyocyte located at the sarcomere Z line, formed by a T-tubule paired with a terminal cisterna of the sarcoplasmic reticulum.
- Conduction velocity
The speed of propagation of an action potential across a cell or multicellular tissue.
Rights and permissions
About this article
Cite this article
Karbassi, E., Fenix, A., Marchiano, S. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol 17, 341–359 (2020). https://doi.org/10.1038/s41569-019-0331-x
This article is cited by
Dynamic chromatin landscape encodes programs for perinatal transition of cardiomyocytes
Cell Death Discovery (2023)
Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside
Basic Research in Cardiology (2023)
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
Cell Biology and Toxicology (2023)
The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome
Journal of Cardiovascular Translational Research (2023)
Recent developments in organ-on-a-chip technology for cardiovascular disease research
Analytical and Bioanalytical Chemistry (2023)